Suppr超能文献

不使用眼科粘弹剂植入可植入式角膜胶原晶状体V4c的安全性一年观察

One-year Observation of Safety of Implantable Collamer Lens V4c Implantation Without Using an Ophthalmic Viscosurgical Device.

作者信息

Chen Zhuoyi, Niu Lingling, Zhao Jing, Yao Peijun, Wang Xiaoying, Zhou Xingtao

机构信息

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.

NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.

出版信息

Front Med (Lausanne). 2022 Feb 14;9:790137. doi: 10.3389/fmed.2022.790137. eCollection 2022.

Abstract

PURPOSE

To investigate the feasibility and safety of the implantable collamer lens V4c (ICL V4c) implantation without using an ophthalmic viscosurgical device (OVD-free technique).

METHODS

This prospective consecutive case study enrolled 118 eyes of 60 patients (15 eyes were of male patients, 103 eyes were of female patients, age 26.19 ± 5.03 years, spherical equivalent -10.05 ± 2.73 D). Eyes were considered for OVD-free or OVD-using ICL V4c implantation based on the maintenance of the anterior segment during the surgery. The follow-up lasted for 12 months. The main measurements were visual acuity and changes in endothelial cell density (ECD) at 12 months.

RESULTS

A total of 75 eyes were included in the OVD-free group and 43 in the OVD group. No infection or other complications were observed in any eye. In the OVD-free group, the safety and efficacy indices were 1.19 ± 0.15 and 1.05 ± 0.20, respectively. 74.5% of the eyes gained one or two lines of corrected distance visual acuity (CDVA), and 25.5% were stable. In the OVD group, the safety and efficacy indices were 1.17 ± 0.17 and 1.03 ± 0.15, respectively; 65.7% of the eyes gained one or two lines of CDVA, and 34.3% were stable. The mean change of ECD was 65.34 cell/ mm compared to the baseline in the OVD-free group and 25.94 cell/ mm compared to baseline in the OVD group ( = 0.038).

CONCLUSIONS

The ICL V4c implantation with an OVD-free technique is a safe and feasible method in eyes with good maintenance of the anterior segment.

摘要

目的

探讨不使用眼科粘弹剂(无粘弹剂技术)植入可植入式胶原晶状体V4c(ICL V4c)的可行性和安全性。

方法

本前瞻性连续病例研究纳入了60例患者的118只眼(男性患者15只眼,女性患者103只眼,年龄26.19±5.03岁,等效球镜度数-10.05±2.73 D)。根据手术过程中前段的维持情况,考虑对眼睛进行无粘弹剂或使用粘弹剂的ICL V4c植入。随访持续12个月。主要测量指标为12个月时的视力和内皮细胞密度(ECD)变化。

结果

无粘弹剂组共纳入75只眼,粘弹剂组纳入43只眼。所有眼中均未观察到感染或其他并发症。在无粘弹剂组中,安全性和有效性指数分别为1.19±0.15和1.05±0.20。74.5%的眼睛矫正远视力(CDVA)提高了一行或两行,25.5%保持稳定。在粘弹剂组中,安全性和有效性指数分别为1.17±0.17和1.03±0.15;65.7%的眼睛CDVA提高了一行或两行,34.3%保持稳定。与基线相比,无粘弹剂组ECD的平均变化为65.34个细胞/mm²,粘弹剂组为25.94个细胞/mm²(P = 0.038)。

结论

对于前段维持良好的眼睛,采用无粘弹剂技术植入ICL V4c是一种安全可行的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验